InvestorsHub Logo
Followers 4
Posts 1608
Boards Moderated 0
Alias Born 09/07/2006

Re: antihama post# 200479

Monday, 11/26/2018 5:46:07 PM

Monday, November 26, 2018 5:46:07 PM

Post# of 701069
Who knows, I mean, it's not the first time, as far as I do remember, that the FDA agrees to change the primary endpoint in an immunotherapy trial. It memory serves me correctly, it also happened a couple of years ago to Neostem on their trial for heart disease. Maybe the co. is in talk with the FDA to change it to OS, too? That news, if positive, would be huge.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News